THE Pharmacy Guild is currently
conducting the national rollout
of MedsASSIST - the codeine
real-time system that will help
pharmacists monitor consumer
use of codeine containing
products to ensure safe and
effective use.
Since the MedsASSIST pilot
commenced in February in
approximately 140 pharmacies
in Newcastle, NSW and North
Queensland regions, we have
collected data on more than
50,000 transactions. The
system is demonstrating its
effectiveness in identifying
patients who may be at risk of
developing codeine dependency.
It is also demonstrating that
the overwhelming majority
of consumers are using these
products safely.
The Guild supports maintaining
the Schedule 3 (Pharmacist Only)
listing for analgesic medicines
containing codeine so the
majority of consumers who
use these products safely and
effectively can continue to have
timely access to these products.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Apr 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Apr 16
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FROM 01 May, pharmacists will be able to dispense Verzenio (abemaciclib) through the PBS to treat Australian patients with an invasive form of early breast cancer that is at high risk of recurring after initial treatment.
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.